Peca Labs, Inc.
StreetZero Signal 68
About Peca Labs, Inc.
PECA Labs is a medical device company focused on bringing new solutions to underserved populations, particularly in cardiovascular care. Founded by Carnegie Mellon alumni including a pediatric surgeon, the company is revolutionizing cardiovascular implantable devices with a polymer platform and novel design approach for vascular grafts and valves. Its products include the exGraft and MASA Valve, designed to fit, grow, and last. Headquarters are at 4424 Penn Avenue, Pittsburgh, PA 15224.
LATEST FUNDINGPrivate Placement
$12.8M
Announced 2026-10-09
TOTAL RAISED$27.1M
IN THE NEWS
EMPLOYEES—
FOUNDED—
HQPittsburgh, PA, United States
Industry
Other Health Care
Tags
Medical DevicesCardiovascularPediatricsPolymeric Devices
Investors
Key highlights
- Raised $12.8M via private placement in Other Health Care sector based in Pittsburgh, PA.
- Total funding reported between $23.26M and $27.1M from multiple investors including Runway Healthcare and Mountain State Capital.
- Received FDA IDE for early feasibility study of MASA Valve polymeric valved conduit in April 2023.
- Headquartered at 4424 Penn Ave, STE 201, Pittsburgh, PA with 31 employees per LinkedIn.
- Developing exGraft and other vascular grafts and heart valves for pediatric and underserved populations.
Ask StreetZero about Peca Labs, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account